SMN1 and proximal spinal muscular atrophy: A recent publication from the NeuroNEXT SMA biomarker study found that SMN protein levels in PBMCs did not correlate with age in healthy infants (under 26 weeks of age), but did decline in SMA patients of the same age range [32].